MedPath

Study of Different Endoscopic Preparations Used in Pediatric Colonoscopy

Conditions
Digestive Illness
Interventions
Drug: Polyethylene Glycol 4000 with electrolytes
Drug: PEG-3350 with electrolytes
Registration Number
NCT04153084
Lead Sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Brief Summary

The aim of this study is to evaluate the quality, acceptance, tolerability and adverse effects of colonoscopy preparations with the different available preparation guidelines.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
126
Inclusion Criteria
  • From 1 to 16 years old.
  • Patients that signed the informed consent form.
Exclusion Criteria
  • Urgent colonoscopy
  • History of intestinal resection
  • Nephropathy, heart disease or metabolic syndrome.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
High volume electrolytes Polyethylene Glycol (PEG 4000) cohortPolyethylene Glycol 4000 with electrolytesPediatric patients who have prepared for a colonoscopy during the years 2018-2019 using high volume electrolytes PEG (Bohm solution®) endoscopic preparation, as part of a diagnostic procedure not related to this study.
Low volume electrolytes PEG (PEG 3350) cohortPEG-3350 with electrolytesPediatric patients who have prepared for a colonoscopy during the years 2018-2019 using low volume electrolytes PEG (Movicol®) endoscopic preparation, as part of a diagnostic procedure not related to this study.
Sodium picosulfate cohortSodium picosulfatePediatric patients who have prepared for a colonoscopy during the years 2018-2019 using sodium picosulfate (Picoprep®) endoscopic preparation, as part of a diagnostic procedure not related to this study.
Primary Outcome Measures
NameTimeMethod
Evaluate the quality of the colonoscopy preparations in our autonomic community comparing different preparation guidelines : Boston ScaleFrom November 2018 to December 2019

The quality of the preparations will be measured using the Boston Bowel Preparation Scale (BBPS), semiquantitative evaluation of the cleanliness of the three colon sections (left, transverse, right) using a score from 0 to 3, giving a total score of 0 (without preparation) to 9 (optimal) and it´s done by two independent observers.

Secondary Outcome Measures
NameTimeMethod
Evaluate the acceptance of the different preparations.From November 2018 to December 2019

The acceptance will be measured using a questionnaire and a quantity record, the questonnaire is made by three items: flavour, odour and volume while the quantity record measures the quantity of preparation ingested by the participant.

Evaluate the tolerance of the different preparations.From November 2018 to December 2019

The tolerance will be measured using a questionnaire and a symptoms record, with a score from 0 (terrible tolerance) to 3 (good tolerance) for each of its items, that are the following: abdominal pain, nausea and vomit, intestinal noises, abdominal distension, burps, flatulences, urgent bowel movements and tenesmus.

Evaluate the security of the different preparations.From November 2018 to December 2019

The security will be measured analysing the existence of adverse effects due to the different preparations.

Trial Locations

Locations (8)

Complejo Hospitalario Torrecárdenas

🇪🇸

Almería, Spain

Hospital Universitario Puerta del Mar

🇪🇸

Cadiz, Cádiz, Spain

Hospital Materno-Infantil de Badajoz

🇪🇸

Badajoz, Spain

Hospital Universitario Reina Sofía

🇪🇸

Córdoba, Spain

Hospital Universitario Virgen Macarena

🇪🇸

Sevilla, Spain

Hospital Universitario Virgen del Rocío

🇪🇸

Sevilla, Spain

Hospital Universitario Virgen de las Nieves

🇪🇸

Granada, Spain

Instituto Hispalense de Pediatría

🇪🇸

Sevilla, Spain

© Copyright 2025. All Rights Reserved by MedPath